Long-Term Study of Mitral Valve Repair With Chord-X
Part of Heart & circulation clinical trials.
This study is for people who have already had a mitral valve repair using a special system called Chord-X. It follows them for 10 years to see how well the repair holds up over the long term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a mitral valve repair procedure using the Chord-X system.
- Your procedure must have happened on or after January 1, 2022.
- You cannot have had any prior mitral valve surgery.
- Your heart's pumping strength (ejection fraction) must be greater than 50% at the time of surgery.
- You must not have had any other heart valve repaired at the same time (except for certain procedures like maze, PFO, or LAA closure).
- You must not have a history of endocarditis or ongoing atrial fibrillation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter-based device to fix a leaky mitral valve without open-heart surgery. It is for people whose severe mitral regurgitation puts them at high risk for traditional surgery.
This trial tests a new robotic tool that gives surgeons a sense of touch during mitral valve repair. If you have a severe leak in your mitral valve and are a good candidate for minimally invasive surgery, this study may offer a way to fix it using the da Vinci robot.
This study keeps track of people who had NeoChord treatment to help understand how well it works in everyday care. You may be included if you had a certain type of mitral valve leakage (regurgitation) and the procedure happened after 2016.
This trial tests a new device to fix a leaky mitral valve without open-heart surgery. It is for people with severe mitral regurgitation who are too high-risk for traditional surgery.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
This trial tests a new device called MRace that may fix a leaky mitral valve without open-heart surgery. It's for people whose valve leaks severely and who can't have standard surgery due to other health issues.
Hear when a new Mitral Regurgitation (MR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.